SUBSCRIBE
SUBSCRIBE

Jecure Therapeutics Inc.

NEWS
Deals
Genentech Takes Aim at NASH, Acquires Jecure Therapeutics
Roche subsidiary Genentech snaps up Jecure and its portfolio of preclinical NLRP3 inhibitors aimed at serious inflammatory diseases.
November 28, 2018
 · 
2 min read
 · 
Alex Keown
NextGen Bio Class of 2018
Bio NC
Top 20 Life Science Startups to Watch in 2018
BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
December 4, 2017
 · 
9 min read
 · 
Mark Terry
3 Biotechs That Could be Taken Out This Quarter
Business
New SoCal Biotech Jecure Therapeutics Makes Debut and Will Take on NASH
February 15, 2017
 · 
3 min read
IN THE PRESS
Deals
Genentech Acquires Jecure Therapeutics
November 27, 2018
 · 
2 min read
Business
Jecure Therapeutics Strengthens Management Team
December 14, 2017
 · 
2 min read
AWARDS
  • NextGen Class of 2018